Loading...
Home 2019-12-03T16:44:08+00:00

Open Science for Children’s Health

M4K Pharma is using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we are aggregating and aligning the work of global academics, foundations and pharma/biotech researchers to advance new cures for childhood diseases not well served by current business models.

M4K Pharma’s first program is the discovery, development and commercialization of an ALK2 enzyme inhibitor which will provide the first therapeutic developed specifically for the treatment of Diffuse Intrinsic Pontine Glioma (DIPG).

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

Real time structural biology support for @M4KPharma and #dipg drug discovery by @thesgconline in @NDMOxford. Completely awesome example of #openscience and use of protein structures in drug discovery. @buildmodels @PDBeurope

TOMORROW: You're invited to join M4K's Scientific Team Update Meeting online. Be a part of open source drug discovery to #defeatDIPG !! Everyone is welcome! Wednesday December 4th(10:00am-12:00pm EST) on Zoom at:
https://t.co/eIejGEztwZ #OpenScience

You're invited to join M4K's Scientific Team Update Meeting online. Be a part of open source drug discovery to #defeatDIPG !! Everyone is welcome! Wednesday December 4th(10:00am-12:00pm EST) on Zoom at:
https://t.co/eIejGEhS8p #OpenScience

If you've missed our November monthly scientific meeting discussing our progress towards a DIPG cure, checkout the summary and full audio recording (with slides) here: https://t.co/5QEUrZxqfM #openscience

Looking forward to speaking at this debate, focused on #patents, #innovation and #OpenScience in the development of new medicines, sharing lessons learned from @O_S_M @OSPInfo. @Wellcome_AMR @prateekbuch @MSF_access @JustTreatment @M4KPharma https://t.co/2EqyCG0BpQ

Load More...

Latest Blog Posts

Partners